A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study

BACKGROUND: Treatment of bipolar disorder (BD) usually requires drug combinations. Combinations of lithium plus valproic acid (Li/VPA) and lithium plus carbamazepine (Li/CBZ) are used in clinical practice but were not previously compared in a head-to-head trial. OBJECTIVE: The objective of this tria...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trials
Hlavní autoři: Missio, Giovani, Moreno, Doris Hupfeld, Demetrio, Frederico Navas, Soeiro-de-Souza, Marcio Gerhardt, dos Santos Fernandes, Fernando, Barros, Vivian Boschesi, Moreno, Ricardo Alberto
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6815353/
https://ncbi.nlm.nih.gov/pubmed/31655626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3655-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky